Congenital Heart

This Congenital Heart Disease channel includes news and new technology to diagnose, treat and manage congenital heart disease. This includes transposed vessels, tetralogy of Fallot, pediatric cardiomyopathy, pulmonary heart valves, pulmonary atresia, patent foramen ovale (PFO),  atrial septal defect (ASD) and ventricular septal defect (VSD). 

extremely premature newborns, patent ductus arteriosus, PDA, hole in the heart, nonsurgical repair, catheter-based intervention
News | Congenital Heart | January 04, 2017

January 4, 2017 — A new minimally invasive technique for repairing the most common...

TeraRecon, WhiteClouds, 3-D printing, 3D Print Packs, RSNA 2016
Technology | Medical 3-D Printing | November 16, 2016

November 16, 2016 — TeraRecon, together with full-color 3-D printing cloud provider WhiteClouds, announced new...

RESPECT trial, Amplatzer PFO Occluder, St. Jude Medical, TCT 2016
News | Structural Heart Occluders | November 02, 2016

November 2, 2016 — St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First...

St. Jude Medical, Amplatzer PFO Occluder, FDA approval, U.S. launch
Technology | Structural Heart Occluders | November 02, 2016

November 2, 2016 — St. Jude Medical Inc. announced this week the U.S. Food and Drug Administration (FDA) approval...

CHOP, Children's Hospital of Philadelphia, prenatal heart surgery, tumor removal, intrapericardial teratoma

Tucker Roussin, 3, is the first survivor of fetal surgery for a life-threatening tumor connected to his heart. Fetal medicine experts at Children's Hospital of Philadelphia successfully removed this tumor. Credit: Children’s Hospital of Philadelphia.

News | Congenital Heart | October 28, 2016

October 28, 2016 — For the first time, fetal medicine experts have performed prenatal...

St. Jude Medical, ADO II AS trial, congenital heart disease, PDA, Amplatzer Duct Occluder II AS
News | Congenital Heart | October 19, 2016

October 19, 2016 — St. Jude Medical Inc. announced the launch of the ADO II AS (AMPLATZER Duct Occluder II...

Xeltis bioabsorbable valve implant, two-year data, EACTS 2016
News | Heart Valve Technology | October 06, 2016

October 6, 2016 — Xeltis announced this week that patients...

Xeltis bioabsorbable pulmonary heart valve, Xplore-I clinical feasibility study, first pediatric implants, EACTS 2016
News | Heart Valve Technology | October 04, 2016

October 4, 2016 — Xeltis recently announced that three pediatric patients have been successfully implanted with the...

Videos | Congenital Heart | October 04, 2016

This video, provided by Xeltis, demonstrates the world’s first bioresorbable heart valve enabling cardiovascular...

congenital heart defects, CHD, risk factors, genes, University of California Irvine research
News | Congenital Heart | September 09, 2016

September 9, 2016 — New research published Sept. 8 in the Open Access journal PLOS Biology reports the role of genes...

ClearFlow, PleuraFlow System, pediatric patients, cardiothoracic surgery
News | Cardiovascular Surgery | August 08, 2016

August 8, 2016 — ClearFlow Inc. announced in late July that its PleuraFlow Active Clearance Technology is now...

ASE, SCCT, SCMR, guideline, multimodality imaging, transposition of the great arteries, TGA
News | Congenital Heart | July 20, 2016

July 20, 2016 — At the end of June, experts from three different medical societies released a new guideline to help...

Dictum Health, telehealth study, IDM100 tablet, neonate cardiology, in-home monitoring
Technology | Telecardiology | July 19, 2016

July 19, 2016 — Dictum Health Inc. announced the launch of a post-U.S. Food and Drug Administration (FDA)-approval...

Cormatrix Cardiovascular, Tyke ECM, extracellular matrix, neonates and infants
News | Congenital Heart | June 30, 2016

June 30, 2016 — CorMatrix Cardiovascular Inc. announced the treatment of the first patients using its CorMatrix Tyke...

Overlay Init